Measles-containing-vaccine second-dose (MCV2) immunization coverage in Americas (WHO region)
Americas (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 78.0% in 2025. ▲ Rising
Latest (2025)
78.0%
Change on year
down 1.3%
Rank
7th
of 11 groups
All-time high
84.0%
in 2018
All-time low
60.0%
in 2007
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Americas (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Americas (WHO region) recorded 78.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
The figure is down 1.3% on the previous year and unchanged over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Americas (WHO region) peaked at 84.0% in 2018 and was at its lowest, 60.0%, in 2007.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 65.0% | — |
| 2001 | 66.0% | +1.5% |
| 2002 | 63.0% | -4.5% |
| 2003 | 61.0% | -3.2% |
| 2004 | 63.0% | +3.3% |
| 2005 | 62.0% | -1.6% |
| 2006 | 61.0% | -1.6% |
| 2007 | 60.0% | -1.6% |
| 2008 | 62.0% | +3.3% |
| 2009 | 66.0% | +6.5% |
| 2010 | 67.0% | +1.5% |
| 2011 | 72.0% | +7.5% |
| 2012 | 73.0% | +1.4% |
| 2013 | 70.0% | -4.1% |
| 2014 | 78.0% | +11.4% |
| 2015 | 78.0% | +0.0% |
| 2016 | 80.0% | +2.6% |
| 2017 | 75.0% | -6.2% |
| 2018 | 84.0% | +12.0% |
| 2019 | 73.0% | -13.1% |
| 2020 | 73.0% | +0.0% |
| 2021 | 77.0% | +5.5% |
| 2022 | 77.0% | +0.0% |
| 2023 | 77.0% | +0.0% |
| 2024 | 79.0% | +2.6% |
| 2025 | 78.0% | -1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 62.9% | 60.0% | 66.0% | 10 |
| 2010s | 75.0% | 67.0% | 84.0% | 10 |
| 2020s | 76.8% | 73.0% | 79.0% | 6 |
More health data for Americas (WHO region)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Total tetanus - number of reported cases, annual growth rate -12.7 % change on previous year (2025)
- Pertussis - number of reported cases 24,640 (2025)
- Total tetanus - number of reported cases 385 (2025)
- Diphtheria - number of reported cases 72 (2025)
- Measles - number of reported cases 12,380 (2025)
- Neonatal tetanus - number of reported cases 23 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Americas (WHO region)?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Americas (WHO region) was 78.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Americas (WHO region)?
- The highest recorded value was 84.0% in 2018.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Americas (WHO region)?
- The lowest recorded value was 60.0% in 2007.
- How does Americas (WHO region) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Americas (WHO region) ranks 7th out of 11 groups with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Americas (WHO region)?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).